SILVER SPRING, Md., Nov. 30, 2017 /PRNewswire-USNewswire/ -- With the approval today of a monthly formulation of the drug buprenorphine for the treatment of opioid use disorder, patients have access to a new and longer-acting option for the treatment of opioid addiction. Millions of...